Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives

Mostafa M. Ghorab; Mansour S. Alsaid; Maureen Higgins; Albena T. Dinkova-Kostova; Abdelaaty A. Shahat; Nehal H. Elghazawy; Reem K. Arafa

doi:10.3109/14756366.2016.1158714

Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives

Mostafa M. Ghorab (Lead / Corresponding author), Mansour S. Alsaid, Maureen Higgins, Albena T. Dinkova-Kostova, Abdelaaty A. Shahat, Nehal H. Elghazawy, Reem K. Arafa

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

173 Downloads (Pure)

Abstract

Reactive oxygen species (ROS) play an integral role in the pathogenesis of most diseases. This work presents the design and synthesis of novel 2-phenylquinazolin-4-amine derivatives (2-12) and evaluation of their NAD(P)H:quinone oxidoreductase 1 (NQO1) inducer activity in murine cells. Also, molecular docking of all the new compounds was performed to assess their ability to inhibit Keap1-Nrf2 protein-protein interaction through occupying the Keap1-Nrf2-binding domain which biologically leads to a consequent Nrf2 accumulation and enhanced gene expression of NQO1. Docking results showed that all compounds have the ability to interact with Keap1; however compound 7, the most active compound in this study, showed more interactions with key amino acids.

Original language	English
Pages (from-to)	1612-1618
Number of pages	7
Journal	Journal of Enzyme Inhibition and Medicinal Chemistry
Volume	31
Issue number	6
Early online date	7 Apr 2016
DOIs	https://doi.org/10.3109/14756366.2016.1158714
Publication status	Published - Apr 2016

Keywords

2-phenylquinazolin-4-amine derivatives
Cytoprotection
Keap1/Nrf2
molecular modeling
NQO1 induction

ASJC Scopus subject areas

Drug Discovery
Pharmacology

Access to Document

10.3109/14756366.2016.1158714

Author Accepted Manuscript
This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry on 07/04/2016, available online: http://www.tandfonline.com/10.3109/14756366.2016.1158714
Accepted author manuscript, 617 KB

Cite this

Ghorab, M. M., Alsaid, M. S., Higgins, M., Dinkova-Kostova, A. T., Shahat, A. A., Elghazawy, N. H., & Arafa, R. K. (2016). Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 31(6), 1612-1618. https://doi.org/10.3109/14756366.2016.1158714

@article{3b238d5cdb944e298bb4e527160a9f82,

title = "Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives",

abstract = "Reactive oxygen species (ROS) play an integral role in the pathogenesis of most diseases. This work presents the design and synthesis of novel 2-phenylquinazolin-4-amine derivatives (2-12) and evaluation of their NAD(P)H:quinone oxidoreductase 1 (NQO1) inducer activity in murine cells. Also, molecular docking of all the new compounds was performed to assess their ability to inhibit Keap1-Nrf2 protein-protein interaction through occupying the Keap1-Nrf2-binding domain which biologically leads to a consequent Nrf2 accumulation and enhanced gene expression of NQO1. Docking results showed that all compounds have the ability to interact with Keap1; however compound 7, the most active compound in this study, showed more interactions with key amino acids.",

keywords = "2-phenylquinazolin-4-amine derivatives, Cytoprotection, Keap1/Nrf2, molecular modeling, NQO1 induction",

author = "Ghorab, {Mostafa M.} and Alsaid, {Mansour S.} and Maureen Higgins and Dinkova-Kostova, {Albena T.} and Shahat, {Abdelaaty A.} and Elghazawy, {Nehal H.} and Arafa, {Reem K.}",

note = "Maureen Higgins and Albena T. Dinkova-Kostova are also grateful to Cancer Research UK (C20953/A10270 and C20953/A18644) for their financial support.",

year = "2016",

month = apr,

doi = "10.3109/14756366.2016.1158714",

language = "English",

volume = "31",

pages = "1612--1618",

journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",

issn = "1475-6366",

publisher = "Informa Healthcare",

number = "6",

}

Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives. / Ghorab, Mostafa M. (Lead / Corresponding author); Alsaid, Mansour S.; Higgins, Maureen et al.
In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 31, No. 6, 04.2016, p. 1612-1618.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Synthesis, molecular modeling and NAD(P)H

T2 - quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives

AU - Ghorab, Mostafa M.

AU - Alsaid, Mansour S.

AU - Higgins, Maureen

AU - Dinkova-Kostova, Albena T.

AU - Shahat, Abdelaaty A.

AU - Elghazawy, Nehal H.

AU - Arafa, Reem K.

N1 - Maureen Higgins and Albena T. Dinkova-Kostova are also grateful to Cancer Research UK (C20953/A10270 and C20953/A18644) for their financial support.

PY - 2016/4

Y1 - 2016/4

N2 - Reactive oxygen species (ROS) play an integral role in the pathogenesis of most diseases. This work presents the design and synthesis of novel 2-phenylquinazolin-4-amine derivatives (2-12) and evaluation of their NAD(P)H:quinone oxidoreductase 1 (NQO1) inducer activity in murine cells. Also, molecular docking of all the new compounds was performed to assess their ability to inhibit Keap1-Nrf2 protein-protein interaction through occupying the Keap1-Nrf2-binding domain which biologically leads to a consequent Nrf2 accumulation and enhanced gene expression of NQO1. Docking results showed that all compounds have the ability to interact with Keap1; however compound 7, the most active compound in this study, showed more interactions with key amino acids.

AB - Reactive oxygen species (ROS) play an integral role in the pathogenesis of most diseases. This work presents the design and synthesis of novel 2-phenylquinazolin-4-amine derivatives (2-12) and evaluation of their NAD(P)H:quinone oxidoreductase 1 (NQO1) inducer activity in murine cells. Also, molecular docking of all the new compounds was performed to assess their ability to inhibit Keap1-Nrf2 protein-protein interaction through occupying the Keap1-Nrf2-binding domain which biologically leads to a consequent Nrf2 accumulation and enhanced gene expression of NQO1. Docking results showed that all compounds have the ability to interact with Keap1; however compound 7, the most active compound in this study, showed more interactions with key amino acids.

KW - 2-phenylquinazolin-4-amine derivatives

KW - Cytoprotection

KW - Keap1/Nrf2

KW - molecular modeling

KW - NQO1 induction

UR - http://www.scopus.com/inward/record.url?scp=84964009499&partnerID=8YFLogxK

U2 - 10.3109/14756366.2016.1158714

DO - 10.3109/14756366.2016.1158714

M3 - Article

C2 - 27052554

SN - 1475-6366

VL - 31

SP - 1612

EP - 1618

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

IS - 6

ER -

Synthesis, molecular modeling and NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this